Stock info arGEN-X | Filter  Basic-Info

Stock: arGEN-X (Belgium 20), ISIN: NL0010832176

Last Price 371.90 Max Price 491.80
Min Price 331.60 1 Year return 17.95
Avg. Target 0.00 Expected Return -100.00 %
Sector Health Care Subsector Biotechnology
Sell 0 Rating
Hold 0 Concensus
Buy 0
Annual report 2017

Loading...

Contact info:Street: Willemstraat 5Zip Code: 4811 AHCountry: BelgiumPhone: +31 (0) 763 030Email: info@argenx.comWebsite: www.argenx.com

Sector Review arGEN-X

Loading...
Year Turnover Total sector Market share
2019 78 141,925 0.06 %
2020 42 170,231 0.02 %
2021 497 252,886 0.20 %
2022 411 238,500 0.17 %
2023 0 0 0.00 %

Advice arGEN-X

Date Label Bank Label Stock Label Advice Label Price Label Diff Label
March 15, 2024 Morgan Stanley arGEN-X Buy 477.00 22.03 %
March 10, 2024 JP Morgan arGEN-X Buy 490.00 24.10 %
February 20, 2024 DeGroof Petercam arGEN-X Buy 502.00 25.92 %
February 13, 2024 Barclays arGEN-X Hold 360.00 -3.31 %
January 19, 2024 KBC Securities arGEN-X Buy 435.00 14.51 %
January 10, 2024 Goldman Sachs arGEN-X Buy 406.00 8.40 %
November 29, 2023 Goldman Sachs arGEN-X Buy 496.00 25.02 %
November 02, 2023 Barclays arGEN-X Buy 550.00 32.38 %
November 01, 2023 JP Morgan arGEN-X Buy 580.00 35.88 %
November 01, 2023 Goldman Sachs arGEN-X Buy 555.00 32.99 %
September 26, 2023 Barclays arGEN-X Buy 540.00 31.13 %
September 18, 2023 KBC Securities arGEN-X Buy 495.00 24.87 %
May 06, 2023 Morgan Stanley arGEN-X Buy 410.00 9.29 %
May 04, 2023 KBC Securities arGEN-X Buy 400.00 7.03 %
March 07, 2023 Goldman Sachs arGEN-X Buy 457.00 24.90 %
February 02, 2023 Bryan Garnier arGEN-X Buy 490.00 28.82 %
January 03, 2023 JP Morgan arGEN-X Buy 500.00 32.62 %
December 16, 2022 Goldman Sachs arGEN-X Buy 453.00 5.74 %
December 06, 2022 Barclays arGEN-X Buy 450.00 9.47 %
November 14, 2022 JP Morgan arGEN-X Buy 480.00 4.06 %
September 22, 2022 Deutsche Bank arGEN-X Buy 425.00 -11.44 %
July 18, 2022 Barclays arGEN-X Buy 390.00 14.69 %
May 13, 2022 Deutsche Bank arGEN-X Buy 320.00 -8.97 %
May 08, 2022 KBC Securities arGEN-X Buy 340.00 -2.56 %
February 14, 2022 Credit Suisse arGEN-X Buy
January 07, 2022 KBC Securities arGEN-X Buy 340.00 -4.44 %
December 20, 2021 Kepler Capital Markets arGEN-X Buy 300.00 -21.83 %
December 04, 2021 Kepler Capital Markets arGEN-X Hold 290.00 -32.79 %
September 02, 2021 Barclays arGEN-X Hold 290.00 -31.62 %
August 04, 2021 JP Morgan arGEN-X Buy 340.00 -7.09 %
August 02, 2021 Goldman Sachs arGEN-X Buy 302.00 -20.56 %
July 22, 2021 Wedbush Morgan Securities arGEN-X Buy 362.00 -1.60 %
July 19, 2021 KBC Securities arGEN-X Buy 300.00 -19.37 %
June 08, 2021 Goldman Sachs arGEN-X Buy 235.00 -23.15 %
May 18, 2021 Goldman Sachs arGEN-X Buy 261.00 -6.90 %
March 09, 2021 Goldman Sachs arGEN-X Buy 290.00 15.31 %
March 09, 2021 Barclays arGEN-X Hold 250.00 1.76 %
March 05, 2021 Bank of America Merrill Lynch arGEN-X Buy
March 05, 2021 Kepler Capital Markets arGEN-X Hold 220.00 -19.05 %
February 10, 2021 Barclays arGEN-X Hold 295.00 16.00 %



News arGEN-X

Analysts expect over 2023 decreasing revenue arGEN-X

Next Monday the Belgian arGEN-X will report its past quarters results. For this year arGEN-X 's (located in ) revenue will be around 1.15 billion euros. This is according to the average of the analysts' estimates. This is quite lower than 2022's revenue of...

Analysts expect over 2021 rising revenue arGEN-X

Tomorrow the Belgian arGEN-X will report its past quarters results. Over the current book year the company from Breda's total revenue could be around 255.99 million euros (consensus estimates). This is quite more than 2021's revenue of 36.43 million euros. Historical...

Analysts expect over 2021 rising revenue arGEN-X

Tomorrow the Belgian company arGEN-X will publish its past quarter results. For this year arGEN-X 's revenue will be around 131.68 million euros. This is according to the average of the analysts' estimates. This is hugely more than 2020's revenue of 36.43 million...

Analysts expect over 2021 decreasing revenue arGEN-X

Tomorrow the Belgian arGEN-X will publish its past quarters figures. For this year arGEN-X 's revenue will be around 63.6 million euros. This is according to the average of the analysts' estimates. This is slightly lower than 2020's revenue of 69.78 millioneuros....

arGEN-X huge outperformer in European biotech sector

Thanks to the huge profit of 57 percent since begin this year it's one of the best shares of the biotech sector. Momentum biotech sector The sector trades now at 261 times the earnings per share. The sector trades at 36,4 times the book value per share. Since...

Annual reports arGEN-X

2017 2018 2019 2020 2021

Profile arGEN-X

arGEN-X

(NL0010832176)/ ARGX

arGEN-X primarily operates in the biotech sector. The global biotech companies gained around 59 percent worldwide over the last 10 years. Measured since 2011 the sector is 70 percent higher and over the past 12 months (December 2015-2016) there is a minus of 59 percent.

The past year was a good year for arGEN-X investors

Over the past year the company' stock gained around 48 percent. Over the period from December 2011 till December 2016 the stock lost on average 0 percent.

The Belgian company didn't pay out any dividends (in the past 5 years).

At the end of 2015 around 31 people were on arGEN-X' payroll.

Quite a lot of debt arGEN-X

At the end of 2015 the Belgian company's balance sheet was worth 45,96 million euros. The total debt of the biotech company was at the end of 2015 8,69 million euros, which equals around 18,91 percent of the total balance sheet. At the end of 2015 the biotech company's stock was traded with a price/earnings-ratio -8. So the stock' value was -8 times the 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the Belgian stock can be seen as a value stock.

At the end of 2015 the Belgian company's market capitalization equaled around 194,19 million euros. At the end of 2015 the Belgian company had around 17,34 million stocks listed on the stock exchange(s).

All arGEN-X's annual reports can be found here. More information about arGEN-X can be found it's website. .


Results arGEN-X

Results
2015
2016
2017
2018
2019
2020
Revenue
8
16
41
25
78
42
Costs
25
40
73
104
259
650
Profit
-17
-24
-32
-79
-181
-608
Margin of profit
-223.55
-145.30
-77.09
-310.18
-232.02
-1465.46
ROI
-41.97
-35.48
-7.65
-12.73
-15.35
-36.35

Balance arGEN-X

Balance
2015
2016
2017
2018
2019
2020
Equity
40
67
414
617
1,180
1,674
Debt
9
45
31
46
430
605
Total assets
50
111
445
663
1,610
2,279
Solvency
81.11
59.92
93.00
93.07
73.31
73.44
Cash
46
102
432
648
1,501
1,996
Cashflow
-15
12
-41
-64
152
-398
Employees
41
58
73
0
0
Revenue per employee
0.19
0.28
0.56
0.0
0.0
Cashflow / Debt
-1.64
0.26
-1.32
-1.38
0.35
-0.66

Details arGEN-X

Details
2016
2017
2018
2019
2020
Price
11.15
15.94
52.52
85.20
143.60
Eps
-1.26
-1.29
-2.35
-4.69
-13.40
Price/earnings-ratio
-8.85
-12.36
-22.35
-18.17
-27.75
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
3.31
12.86
17.16
27.60
35.19
Market to book
0.30
0.81
0.33
0.32
0.09
Cashflow per stock
0.58
-1.28
-1.77
3.55
-8.38
Stocks
20
32
36
43
48
Market Cap
224.41
512.96
1.889.42
3.643.28
17.691.77

Dividend arGEN-X


Price info arGEN-X

Date
Price
22 Mar 2024
371.90
18 Mar 2024
333.20
15 Mar 2024
347.80
12 Mar 2024
356.60
11 Mar 2024
356.90
09 Mar 2024
356.90
07 Mar 2024
358.20
01 Mar 2024
343.20
29 Feb 2024
368.50
27 Feb 2024
376.20
22 Feb 2024
369.90
21 Feb 2024
366.30
20 Feb 2024
369.00
15 Feb 2024
361.30
14 Feb 2024
361.80
13 Feb 2024
362.40
09 Feb 2024
363.20
08 Feb 2024
363.20
07 Feb 2024
363.10
06 Feb 2024
371.20
05 Feb 2024
350.10
01 Feb 2024
348.80
31 Jan 2024
348.80
30 Jan 2024
351.90
27 Jan 2024
352.40
25 Jan 2024
336.80
24 Jan 2024
336.30
23 Jan 2024
334.90
16 Jan 2024
348.00
11 Jan 2024
361.30